Form 8-K - Current report:
SEC Accession No. 0001654954-22-007369
Filing Date
2022-05-23
Accepted
2022-05-23 16:32:14
Documents
16
Period of Report
2022-05-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tenx_8k.htm   iXBRL 8-K 21513
2 EX-99.1 tenx_ex991.htm EX-99.1 12558
8 tenx_ex991img1.jpg GRAPHIC 4244
  Complete submission text file 0001654954-22-007369.txt   168612

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tenx-20220523.xsd EX-101.SCH 5830
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tenx-20220523_lab.xml EX-101.LAB 14763
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tenx-20220523_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tenx-20220523_pre.xml EX-101.PRE 9371
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tenx-20220523_def.xml EX-101.DEF 2103
10 EXTRACTED XBRL INSTANCE DOCUMENT tenx_8k_htm.xml XML 3610
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 22952163
SIC: 2834 Pharmaceutical Preparations